Condition

Connective Tissue Disease

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 9 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials9

Recruiting2

Common interventions14

Lead sponsors shown8

Clinical trials

9 shown

AYLo - AutoimmunitY and Loss of yNCT06696027 · 2024-11-15

RECRUITING

Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related DisordersNCT07477197 · 2021-07-01

RECRUITING

Personalized Outreach for Equitable Treatment in RheumatologyNCT07022756 · 2025-07-02

NOT_YET_RECRUITING

A Clinical Trial for CTD-ILD TreatmentNCT01424033 · 2011-12-01

TERMINATED

Exercise and Respiratory Therapy in Patients With Rheumatoid Arthritis / Collagenosis and Pulmonary HypertensionNCT00491309 · 2011-07-01

UNKNOWN

Auto-immunity and Pulmonary Arterial HypertensionNCT01208792 · 2010-06-15

COMPLETED

Early Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue DiseasesNCT01387035 · 2010-01-01

UNKNOWN

A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic SclerosisNCT01042158 · 2010-01-01

COMPLETED

A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue DiseaseNCT00864201 · 2009-04-01

UNKNOWN

Common interventions

3'mRNA sequencingDIAGNOSTIC_TEST1 Assessment of Pulmonary InvolvementDIAGNOSTIC_TEST1 Blood SampleOTHER1 bosentanDRUG1 Enzyme-linked immunosorbent assay (ELISA) and Legendplex ArrayDIAGNOSTIC_TEST1 exercise trainingBEHAVIORAL1 Flow CytometryDIAGNOSTIC_TEST1 HonorariaBEHAVIORAL1 Laboratory assessmentDIAGNOSTIC_TEST1 N-AcetylcysteineDRUG1 OutreachBEHAVIORAL1 Single nucleotide polymorphisms (SNP)DIAGNOSTIC_TEST1 skin biopsyPROCEDURE1 tadalafil and ambrisentan upfront combination therapyDRUG1

Leading sponsors

Heidelberg University 2 Assistance Publique - Hôpitaux de Paris 1 Children's Hospital Medical Center, Cincinnati 1 Hamilton Health Sciences Corporation 1 Johns Hopkins University 1 University of Bonn 1 University of British Columbia 1 University of Michigan 1

Trial status mix

UNKNOWN3

COMPLETED2

RECRUITING2

NOT_YET_RECRUITING1

TERMINATED1

Phase mix

NA3

PHASE32

PHASE21

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.